A new recognition has added to the Centre for advanced studies of chronic diseases (ACCDiS ) being selected as the third research hub among all such institutions in the country according to the latest report issued by the SCImago Institutions Ranking (SIR).

This center, which was founded in 2013, seeks to be a reference in "transdisciplinary research and advanced human resources training in chronic diseases" with its work in the field through the "generation of specialized knowledge about genetic elements, determine the development of cardiovascular disease and cancer".

Recognition comes due to the contribution made by the ACCDiS in the three indicators used by the SIR in its measurements: research performance, innovation and social impact results, where the center supported by UC Medical School is highlighted as one of the best, mainly in the innovation aspect, ranking in which he achieves the first national place.

At the Latin American level the center also stands out among the top 30. In both, in the innovation aspect, reached seventh place in the region.

During these seven years of operation, ACCDiS has worked on six lines of research: metabolic signaling in heart failure, run by Dr. Sergio Lavandero; biomarkers and gender differences in heart failure, directed by the doctor Pablo Castro; tumor cell biology and inflammation, with the leadership of Andrew Quest, PhD; epigenomic scenarios in gastric cancer, with the doctor's address Alejandro Corvalan; natural history of digestive cancer, led by the doctor Catterina Ferreccio; and Nanomedicine for the diagnosis and therapy of cancer and cardiovascular disease, by Marcelo Kogan, PhD.

Led by Dr. Lavandero as director of the center and Dr. Ferreccio as deputy director, in addition to the support of the Catholic University of Chile and the University of Chile, together with the NATIONAL Agency for Research and Development's FONDAP Program (ANID) and partner institutions, this center has achieved the excellence that currently positions it as one of the best in the country.

See full story on: medicina.uc.cl